Related Experiment Video
Updated: Apr 29, 2026

Assaying the Kinase Activity of LRRK2 in vitro
Published on: January 18, 2012
Structural biology of the LRRK2 GTPase and kinase domains: implications for regulation
Bernd K Gilsbach1, Arjan Kortholt1
1Department of Cell Biochemistry, University of Groningen Groningen, Netherlands.
Abstract:
Human leucine rich repeat kinase 2 (LRRK2) belongs to the Roco family of proteins, which are characterized by the presence of a Ras-like G-domain (Roc), a C-terminal of Roc domain (COR), and a kinase domain. Mutations in LRRK2 have been found to be thus far the most frequent cause of late-onset Parkinson's disease (PD). Several of the pathogenic mutations in LRRK2 result in decreased GTPase activity and enhanced kinase activity, suggesting a possible PD-related gain of abnormal function. Important progress in the structural understanding of LRRK2 has come from our work with related Roco proteins from lower organisms. Atomic structures of Roco proteins from prokaryotes revealed that Roco proteins belong to the GAD class of molecular switches (G proteins activated by nucleotide dependent dimerization). As in LRRK2, PD-analogous mutations in Roco proteins from bacteria decrease the GTPase reaction. Studies with Roco proteins from the model organism Dictyostelium discoideum revealed that PD mutants have different effects and most importantly they explained the G2019S-related increased LRRK2 kinase activity. Furthermore, the structure of Dictyostelium Roco4 kinase in complex with the LRRK2 inhibitor H1152 showed that Roco4 and other Roco family proteins can be important for the optimization of the current, and identification of new, LRRK2 kinase inhibitors. In this review we highlight the recent progress in structural and biochemical characterization of Roco proteins and discuss its implication for the understanding of the complex regulatory mechanism of LRRK2.
Insights
Structural studies of Roco proteins offer insights into leucine-rich repeat kinase 2 (LRRK2) regulation. Understanding these G proteins is key to developing new treatments for Parkinson
Area of Science:
- Biochemistry
- Structural Biology
- Neuroscience
Background:
- Leucine-rich repeat kinase 2 (LRRK2) is implicated in Parkinson's disease (PD) pathogenesis.
- LRRK2 mutations can lead to altered GTPase and kinase activity, suggesting a gain of function.
- Roco proteins share structural similarities with LRRK2, providing models for functional studies.
Purpose of the Study:
- To review progress in the structural and biochemical characterization of Roco proteins.
- To discuss the implications of Roco protein research for understanding LRRK2 regulation.
- To explore the potential of Roco proteins in the development of LRRK2 inhibitors.
Main Methods:
- Analysis of atomic structures of Roco proteins from prokaryotes and Dictyostelium discoideum.
- Biochemical characterization of PD-associated mutations in Roco proteins.
- Structural studies of Roco4 kinase in complex with LRRK2 inhibitors.
Main Results:
- Prokaryotic Roco proteins function as nucleotide-dependent dimerization switches.
- PD-analogous mutations in bacterial Roco proteins decrease GTPase activity.
- Dictyostelium Roco protein studies elucidated the mechanism behind G2019S-related LRRK2 kinase hyperactivity.
Conclusions:
- Structural and biochemical insights from Roco proteins advance the understanding of LRRK2.
- Roco proteins serve as valuable models for studying LRRK2 function and dysfunction in Parkinson's disease.
- Roco proteins are crucial for optimizing existing and identifying novel LRRK2 kinase inhibitors.
Related Concept Videos
Assembly of Signaling Complexes
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Receptor Tyrosine Kinases
Amplifying Signals via Enzymatic Cascade
GTPases and their Regulation
Large G-proteins,...
GTPases and their Regulation
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:

